Trial Profile
Comparative Analysis of Immune Profile Following Neoadjuvant Chemotherapy in Colorectal Liver Metastases (CRLM): A Prospective Pilot Clinical Trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Feb 2024
Price :
$35
*
At a glance
- Drugs Atezolizumab (Primary) ; Bevacizumab (Primary) ; Fluorouracil (Primary) ; Folinic acid (Primary) ; Oxaliplatin (Primary)
- Indications Adenocarcinoma; Colorectal cancer; Liver metastases
- Focus Pharmacodynamics
- Acronyms CLIMB
- 29 Jan 2024 Status changed from active, no longer recruiting to completed.
- 03 Apr 2023 Planned End Date changed from 1 Dec 2023 to 31 Dec 2023.
- 20 Jul 2021 Planned End Date changed from 1 Sep 2022 to 1 Dec 2023.